Home
Categories
Ingredients
Analysis
Manufacturing
Finance
Regulatory
Drug Delivery
Research & Development
Sustainability
Pharma 5.0
Company News
Events
Directory
Search
Close search
Home
Company
Inovio
Inovio
Activities:
Regulatory
Research & Development
Pharmaceutical
X
LinkedIn
Trending Articles
Agilent boosts contract manufacturing capabilities with acquisition of BIOVECTRA
The CDMO acquisition will bolster Agilent's end-to-end production capabilities in a number of popular therapeutics, including GLP-1 medications and ADCs
KBI Biopharma extends contract with a big pharma giant after a successful FDA inspection
The contract has been renewed and extended until at least 2029, and will now include the purchase of two therapeutic products
Currax to build novel anti-obesity treatment production facility amidst GLP-1 supply issues
The manufacturing facility will be dedicated to the production of anti-obesity drug Contrave, and will double its output in the EU and EEA
New FAIRY viral assay could 'revolutionise' the response to future pandemics
The assay, which can detect the infectiousness of a virus in a matter of minutes, offers a quicker and cheaper alternative to the standard cell culture approach
New advice from BOLA and Labtex on cleaning and handling of PTFE products after use
The companies share: "Abrasive scouring agents may result in a milkiness of the vessels made of PFA and FEP. You may use all neutral detergents (pH 7). For higher contamination...
Upcoming event
ISPE Singapore
28-30 August 2024 | Conference and exhibition | Singapore
See all
Related Content
You need to be a subscriber to read this article.
Click here
to find out more.
Pharmaceutical
Zika outbreak gives rise to global fears
Zika may not be a new virus but its newly confirmed ability to cause foetal brain abnormalities makes the search for a treatment or a vaccine a high priority. Dr Sarah Houlton looks at the latest initiatives
Drug Delivery
Inovio to buy needle-free injection technology from Bioject Medical Technologies for US$5.5m
Non-invasive integrated injection and electroporation device could enhance mass immunisation against infectious diseases
Research & Development
AstraZeneca signs third cancer deal in seven days
MedImmune enters into cancer vaccine collaboration and license agreement with Inovio Pharmaceuticals
Research & Development
Inovio Pharmaceuticals, MedImmune and the University of Pennsylvania join forces to tackle influenza and antibiotic-resistant bacteria
The project is awarded US$12.2m by US Defense Advanced Research Projects Agency (DARPA)
Research & Development
Inovio Pharmaceuticals continues building senior team with appointment of VP of Quality
Also makes three promotions in Legal, Clinical and Investor Relations
Drug Delivery
Inovio and US army receive US$3.5m grant
To continue development of a mass vaccination device using electroporation technology
Research & Development
PATH Malaria Vaccine Initiative and Inovio to accelerate malaria vaccine development
Follow-on agreement will lead to clinical trials
Subscribe now